채용
Translational Scientist II, Translational Research
New York City; Boston; Chicago
·
On-site
·
Full-time
·
6d ago
Passionate about precision medicine and advancing the healthcare industry?
Recent advancements in underlying technology have finally made it possible for AI to impact clinical care in a meaningful way. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.
Translational Scientist II, Translational Research
With the advent of genomic sequencing, we can finally decode and process our genetic makeup; however, computer technology has had a limited impact in healthcare. With the expansion of multi-modal healthcare data and recent advancements in AI, that’s about to fundamentally change. Tempus is a healthcare technology company at the forefront of that change by leveraging data to improve patient lives.
Tempus' proprietary data and platform connect an entire ecosystem of real-world data to deliver real-time, actionable insights to physicians. Our data empowers researchers to better characterize and understand disease, and to drive better outcomes through precise, individualized care.
The Translational Scientist II, Translational Research will execute research projects for early stage biopharmaceutical partners. This role involves performing complex computational analyses, and providing interpreted insights to guide decision-making for biopharma clients. The ideal candidate will possess strong genomic analytical skills and the ability to communicate complex scientific findings to various stakeholders.
Key Responsibilities:
-
Independent Contribution: Independently execute complex translational research projects integrating molecular and clinical data from Tempus multimodal data platform to derive real-world insights for biopharma partners
-
Scientific Communication: Present scientific findings clearly and meaningfully to diverse sets of external stakeholders
-
Continuous Improvement: Stay current with industry trends, best practices, and advancements in computational oncology research. Apply this knowledge to enhance research methodologies and improve overall research quality on team
Qualifications:
-
Education: PhD degree in a quantitative discipline (e.g. Biostatistics/Statistical Genetics, Cancer Genetics, Bioinformatics, Computational Biology, Computational Immunology or similar) or, a PhD in Molecular Biology or Immunology combined with a very strong record of computational biology. Alternatively an MSc degree with 4+ years of industry experience.
-
Technical/Scientific Skills: Highly proficient in R (ideally Rmd and/or RShiny)
-
Communication Skills: Excellent written and verbal communication skills, with the ability to present complex information clearly and persuasively to diverse audiences.
Preferred Skillsets/Background:
-
Strong understanding of molecular data and artificial intelligence in drug discovery with experience in integrative modeling of multi-modal clinical and omics data.
-
Previous experience working with large transcriptome and NGS data sets.
-
Prior consulting and/or client facing experience is highly desirable
-
Ability to work collaboratively in a team environment
-
Thrive in a fast-paced environment and willing to shift priorities seamlessly.
-
Experience with R package development.
-
Strong peer-reviewed publication record.
-
Experience with: Pandas, Num Py, Sci Py, Scikit-learn, Jupyter Notebooks, RStudio, R Package development, tidyverse, ggplot, Git, matplotlib, seaborn, HTML5, CSS3, JavaScript, D3, Plot.ly, Flask, Dask, Docker, AWS.
-
Goal orientation, self motivation, and drive to make a positive impact in healthcare.
CHI: $90,000-$135,000
NYC/SF: $100,000-$150,000
The expected salary range above is applicable if the role is performed from Illinois and may vary for other locations (California, Colorado, New York). Actual salary may vary based on qualifications and experience. Tempus offers a full range of benefits, which may include incentive compensation, restricted stock units, medical and other benefits depending on the position.
We are an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
Total Views
0
Apply Clicks
0
Mock Applicants
0
Scraps
0
Similar Jobs

Senior Scientist, Precision Biomarkers & MultiOmics Integration
Johnson & Johnson · 2 Locations

Senior Data Scientist, Product
Robinhood · Menlo Park, CA

Senior Scientist, R&D - Product Development
Kraft Heinz · Warrendale, PA

Manager, Data Scientist - Alternative Data Strategy
Capital One · 2 Locations

Research Scientist, Science of Post-Training and Reinforcement Learning
Google DeepMind · London, UK
About Tempus
Tempus
PublicTempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer.
501-1,000
Employees
Chicago
Headquarters
Reviews
3.7
9 reviews
Work Life Balance
3.2
Compensation
3.5
Culture
2.8
Career
2.5
Management
2.3
65%
Recommend to a Friend
Pros
Helping clients/people in need
Good benefits and support
Supportive coworkers and staff
Cons
Poor management and leadership
Time constraints and pressure
Limited training during changes
Salary Ranges
23 data points
Junior/L3
Mid/L4
Senior/L5
Staff/L6
Junior/L3 · Data Scientist
0 reports
$149,500
total / year
Base
-
Stock
-
Bonus
-
$127,075
$171,925
Interview Experience
53 interviews
Difficulty
3.5
/ 5
Duration
14-28 weeks
Offer Rate
39%
Experience
Positive 64%
Neutral 26%
Negative 10%
Interview Process
1
Phone Screen
2
Technical Interview
3
System Design
4
Behavioral
5
Team Fit
Common Questions
Tell me about a challenging project
System design question
Coding problem
Why this company
News & Buzz
Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells 166,250 Shares of Stock - MarketBeat
Source: MarketBeat
News
·
7w ago
TEM vs. DOCS: Which Medical-Tech Stock Looks Promising Amid AI Boom? - TradingView
Source: TradingView
News
·
7w ago
21,000 Shares in Tempus AI, Inc. $TEM Purchased by Hussman Strategic Advisors Inc. - MarketBeat
Source: MarketBeat
News
·
7w ago
Should Tempus AI’s (TEM) New Immunotherapy Prediction Data Shift How Investors View Its Moat? - simplywall.st
Source: simplywall.st
News
·
7w ago